Fmoc-PEG6-VCP-Eribulin

Overview

Fmoc-PEG6-VCP-Eribulin is the derivative of Eribulin ( HY-13442 ). Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer . Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Drug Derivative | Products > Signaling Pathways > ADC Payloads | Products > Signaling Pathways > Microtubule/Tubulin

Product Information

• Catalog No.: HY-177549
• CAS No.: 2841688-52-4
• Molecular Formula: C89H125N7O25
• Molecular Weight: 1692.98
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source